Increased Expression of P-Glycoprotein Is Associated with Doxorubicin Chemoresistance in the Metastatic 4T1 Breast Cancer Model
- 1 February 2011
- journal article
- research article
- Published by Elsevier
- Vol. 178 (2) , 838-852
- https://doi.org/10.1016/j.ajpath.2010.10.029
Abstract
No abstract availableFunding Information
- NIH National Cancer Institute (CA127481, CA129776)
- Louisiana Cancer Research Consortium
- Tulane Cancer Center
This publication has 48 references indexed in Scilit:
- Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancerNature Medicine, 2010
- Small-Molecule Multidrug Resistance–Associated Protein 1 Inhibitor Reversan Increases the Therapeutic Index of Chemotherapy in Mouse Models of NeuroblastomaCancer Research, 2009
- Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cellsAnti-Cancer Drugs, 2009
- Imagable 4T1 model for the study of late stage breast cancerBMC Cancer, 2008
- Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the WorldJournal of Clinical Oncology, 2006
- Targeting multidrug resistance in cancerNature Reviews Drug Discovery, 2006
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005
- Orthotopic models of cancer for preclinical drug evaluationEuropean Journal Of Cancer, 2004
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002